{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:36:24Z","timestamp":1794062184283,"version":"4.8.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70114655"],"award-info":[{"award-number":["70114655"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["09R\/2022"],"award-info":[{"award-number":["09R\/2022"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["101119855"],"award-info":[{"award-number":["101119855"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 01ZZ2322A"],"award-info":[{"award-number":["FKZ 01ZZ2322A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["EkoEstMed-FKZ 01ZZ2015"],"award-info":[{"award-number":["EkoEstMed-FKZ 01ZZ2015"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI056299"],"award-info":[{"award-number":["P01 AI056299"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 AI34495"],"award-info":[{"award-number":["R37 AI34495"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["259373024\\u2014TRR167"],"award-info":[{"award-number":["259373024\\u2014TRR167"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["441891347\\u2014SFB1479"],"award-info":[{"award-number":["441891347\\u2014SFB1479"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["256073931\\u2014CRC1160"],"award-info":[{"award-number":["256073931\\u2014CRC1160"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["431984000\\u2014CRC1453"],"award-info":[{"award-number":["431984000\\u2014CRC1453"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["491676693-Z01\\u2014TRR359"],"award-info":[{"award-number":["491676693-Z01\\u2014TRR359"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["101094168"],"award-info":[{"award-number":["101094168"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["7030-23"],"award-info":[{"award-number":["7030-23"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","award":["10.001.317"],"award-info":[{"award-number":["10.001.317"]}],"id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","award":["FR01-375"],"award-info":[{"award-number":["FR01-375"]}],"id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["733 310030_170320"],"award-info":[{"award-number":["733 310030_170320"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_188450"],"award-info":[{"award-number":["310030_188450"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSII5_183478"],"award-info":[{"award-number":["CRSII5_183478"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ccell.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T10:41:11Z","timestamp":1739184071000},"page":"269-291.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity"],"prefix":"10.1016","volume":"43","author":[{"given":"Lukas M.","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Giesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Andrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Riemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Talvard-Balland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Duquesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamina","family":"R\u00fcckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kreutmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Zwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Follo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Osswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Melchinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Haferkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Torster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"K\u00f6tt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Gebhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Karantzelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Wallrabenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Lowinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Brehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Rawluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bronsert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Heikenw\u00e4lder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar P.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schmitt-Graeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Ceteci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian R.","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Boerries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Duyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ihorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Lassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Keye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Minguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Ugurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rafei-Shamsabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hasselblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Bengsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika L.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Meiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Funke-Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Malte","family":"Placke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petya","family":"Apostolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-3393","authenticated-orcid":false,"given":"Robert","family":"Zeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.01.004_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177460","article-title":"Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice","volume":"134","author":"Talvard-Balland","year":"2024","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2025.01.004_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7729","article-title":"Oncogenic JAK2(V617F) causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms","volume":"10","author":"Prestipino","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1200\/JCO.2015.66.1389","article-title":"Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma","volume":"35","author":"Weber","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib5","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib6","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.jtho.2021.06.024","article-title":"Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events","volume":"16","author":"Luo","year":"2021","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib7","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1200\/JCO.2015.60.8448","article-title":"Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center","volume":"33","author":"Horvat","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132334","article-title":"MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors","volume":"5","author":"Marschner","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ccell.2025.01.004_bib9","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1002\/cncr.31629","article-title":"High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma","volume":"124","author":"Faje","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib10","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.2018.79.0006","article-title":"Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer","volume":"36","author":"Arbour","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030546","article-title":"Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis","volume":"12","author":"Petrelli","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ccell.2025.01.004_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-Related Adverse Events Associated with Immune Checkpoint Blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib13","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.7150\/jca.87335","article-title":"The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review","volume":"14","author":"Machado","year":"2023","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/1078-0432.CCR-20-3449","article-title":"Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial","volume":"27","author":"Montfort","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib15","article-title":"COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis","volume":"10","author":"Holmstroem","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib16","article-title":"Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study","volume":"9","author":"Zou","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40425-018-0461-4","article-title":"Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study","volume":"6","author":"Abu-Sbeih","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib18","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1111\/ajco.12651","article-title":"Infliximab for ipilimumab-induced colitis: A series of 13 patients","volume":"13","author":"Hillock","year":"2017","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/mco.2021.2227","article-title":"Efficacy and safety of Infliximab for steroid-resistant immune-related adverse events: A retrospective study","volume":"14","author":"Kadokawa","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results","volume":"316","author":"Edelson","year":"1987","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib21","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41375-022-01701-2","article-title":"Extracorporeal photopheresis in acute and chronic steroid-refractory graft-versus-host disease: an evolving treatment landscape","volume":"36","author":"Greinix","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2025.01.004_bib22","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199812103392404","article-title":"Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group","volume":"339","author":"Barr","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/adc.85.2.149","article-title":"Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial","volume":"85","author":"Ludvigsson","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ccell.2025.01.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103172","article-title":"Analysis of extracorporeal photopheresis within the frame of the WAA register","volume":"60","author":"Blaha","year":"2021","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.ccell.2025.01.004_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jca.21957","article-title":"Infectious risks in patients treated with extracorporeal photopheresis for graft-versus-host disease: A retrospective cohort study","volume":"37","author":"Thevenet","year":"2022","journal-title":"J.\u00a0Clin. Apher."},{"key":"10.1016\/j.ccell.2025.01.004_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJMc1912274","article-title":"Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy","volume":"382","author":"Apostolova","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clim.2010.01.018","article-title":"Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice","volume":"135","author":"Xia","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib28","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/db06-0825","article-title":"Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice","volume":"56","author":"Xia","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ccell.2025.01.004_bib29","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-11-125542","article-title":"Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T\u00a0cells","volume":"112","author":"Gatza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.01.004_bib30","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.4049\/jimmunol.181.9.5956","article-title":"Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T\u00a0cells","volume":"181","author":"Maeda","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2249.2007.03577.x","article-title":"Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients","volume":"151","author":"Di Renzo","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib32","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events","volume":"8","author":"Maus","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/0008-5472.CAN-18-1397","article-title":"miR-146a Controls Immune Response in the Melanoma Microenvironment","volume":"79","author":"Mastroianni","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lungcan.2015.01.019","article-title":"Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma","volume":"88","author":"Wieckowski","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib35","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.immuni.2022.09.014","article-title":"Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy","volume":"55","author":"Denk","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.01.004_bib36","first-page":"3358","article-title":"Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes","volume":"46","author":"Salup","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1162-y","article-title":"Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy","volume":"569","author":"Perez-Ruiz","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.01.004_bib38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.06.001","article-title":"Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy","volume":"182","author":"Luoma","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.01.004_bib39","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1053\/j.gastro.2021.06.025","article-title":"Interferon-Gamma-Producing CD8(+) Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis","volume":"161","author":"Sasson","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2025.01.004_bib40","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4","volume":"24","author":"Beck","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib41","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.4049\/jimmunol.166.6.3804","article-title":"MHC-II-independent CD4+ T\u00a0cells induce colitis in immunodeficient RAG-\/- hosts","volume":"166","author":"Trobonjaca","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib42","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/eji.202149530","article-title":"GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity","volume":"52","author":"Zeiser","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi1501","article-title":"Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease","volume":"16","author":"Czech","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","article-title":"Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte","volume":"123","author":"Gardai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.01.004_bib45","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41467-019-12384-2","article-title":"Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24","volume":"10","author":"Yu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.01.004_bib46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","article-title":"Development and validation of the Nancy histological index for UC","volume":"66","author":"Marchal-Bressenot","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ccell.2025.01.004_bib48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2468-1253(20)30014-5","article-title":"British\u00a0Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis","volume":"5","author":"Powell","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ccell.2025.01.004_bib49","first-page":"2327","article-title":"Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-alpha and Modulated by IL23R Genotype Status","volume":"21","author":"Stallhofer","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ccell.2025.01.004_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.01.004_bib51","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.1912774117","article-title":"ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.01.004_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ccell.2025.01.004_bib53","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in\u00a0vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and Function of Interleukin-2 in T Lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib55","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/jamaoncol.2022.5041","article-title":"Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma","volume":"8","author":"van Not","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108031","article-title":"Corticosteroid administration for cancer-related indications is an unfavorable prognostic factor in solid cancer patients receiving immune checkpoint inhibitor treatment","volume":"99","author":"Wang","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ccell.2025.01.004_bib57","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41591-019-0566-4","article-title":"Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity","volume":"25","author":"Yang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib58","article-title":"Inhibition of IL-25\/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity","volume":"12","author":"Hu","year":"2024","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib59","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.4049\/jimmunol.170.4.2004","article-title":"TNF plays an essential role in tumor regression after adoptive transfer of perforin\/IFN-gamma double knockout effector T\u00a0cells","volume":"170","author":"Poehlein","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2025.01.004_bib60","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1172\/JCI33522","article-title":"IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers","volume":"118","author":"Zhang","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2025.01.004_bib61","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/0008-5472.CAN-04-3612","article-title":"Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation","volume":"65","author":"Villeneuve","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib62","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2025.01.004_bib63","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","article-title":"Adiponectin and its receptors are expressed in bone-forming cells","volume":"35","author":"Berner","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.ccell.2025.01.004_bib64","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fphys.2018.00982","article-title":"Adiponectin and Orexin-A as a Potential Immunity Link Between Adipose Tissue and Central Nervous System","volume":"9","author":"Polito","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ccell.2025.01.004_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ccell.2025.01.004_bib66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib67","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","article-title":"Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype","volume":"285","author":"Ohashi","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2025.01.004_bib68","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1016\/j.febslet.2005.11.019","article-title":"Adiponectin inhibits Toll-like receptor family-induced signaling","volume":"579","author":"Yamaguchi","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ccell.2025.01.004_bib69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.apsb.2023.10.019","article-title":"Adiponectin restores the obesity-induced impaired immunomodulatory function of mesenchymal stromal cells via glycolytic reprogramming","volume":"14","author":"Pham","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ccell.2025.01.004_bib70","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1161\/01.CIR.0000127953.98131.ED","article-title":"Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages","volume":"109","author":"Kumada","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccell.2025.01.004_bib71","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41556-022-00909-9","article-title":"Adiponectin receptors sustain haematopoietic stem cells throughout adulthood by protecting them from inflammation","volume":"24","author":"Meacham","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2025.01.004_bib72","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib73","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191054","article-title":"Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling","volume":"218","author":"Wang","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib74","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1182\/blood-2010-06-287839","article-title":"Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13","volume":"116","author":"Highfill","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.01.004_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T\u00a0cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.01.004_bib76","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41409-020-01122-8","article-title":"Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease","volume":"56","author":"Maas-Bauer","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ccell.2025.01.004_bib77","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib78","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib79","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/apt.17201","article-title":"Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis","volume":"56","author":"Dahl","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ccell.2025.01.004_bib80","article-title":"Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab","volume":"9","author":"Alexander","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CJI.0000000000000268","article-title":"Incidence and Clinical Impact of Anti-TNFalpha Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey","volume":"42","author":"Lesage","year":"2019","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ccell.2025.01.004_bib82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/CMR.0000000000000543","article-title":"Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis","volume":"29","author":"Mir","year":"2019","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib83","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jgh3.12531","article-title":"Calcineurin inhibitors in steroid and anti-TNF-alpha refractory immune checkpoint inhibitor colitis","volume":"5","author":"Zhang","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.ccell.2025.01.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115049","article-title":"Extracorporeal photopheresis vs. systemic immunosuppression for immune-related adverse events: Interim analysis of a prospective two-arm study","volume":"212","author":"Ertl","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib85","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMc2031717","article-title":"Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors","volume":"384","author":"Thomas","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib86","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1056\/NEJMc2002527","article-title":"Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy","volume":"382","author":"Esfahani","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jgh3.12868","article-title":"Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study","volume":"7","author":"Kadokawa","year":"2023","journal-title":"JGH Open"},{"key":"10.1016\/j.ccell.2025.01.004_bib88","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ccr3.3597","article-title":"Successful mycophenolate mofetil treatment of a patient with severe steroid-refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer","volume":"9","author":"Omori","year":"2021","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.ccell.2025.01.004_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omaa027","article-title":"Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis","volume":"2020","author":"Nakano","year":"2020","journal-title":"Oxf. Med. Case Rep."},{"key":"10.1016\/j.ccell.2025.01.004_bib90","article-title":"Mycophenolate mofetil for immune checkpoint inhibitor-related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review","volume":"5","author":"Ueno","year":"2022","journal-title":"Cancer Rep."},{"key":"10.1016\/j.ccell.2025.01.004_bib91","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000001007","article-title":"Tacrolimus for the Management of Delayed Onset and Treatment-Refractory Immune-Related Hepatitis","volume":"10","author":"Ea","year":"2023","journal-title":"ACG Case Rep. J."},{"key":"10.1016\/j.ccell.2025.01.004_bib92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/14782715221088911","article-title":"The use of tacrolimus in the management of checkpoint inhibitor immunotherapy-induced hepatitis","volume":"52","author":"McIlwaine","year":"2022","journal-title":"J.\u00a0R. Coll. Physicians Edinb."},{"key":"10.1016\/j.ccell.2025.01.004_bib93","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1200\/JCO.2010.32.2206","article-title":"Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy","volume":"29","author":"Chmiel","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.01.004_bib94","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/hep.31396","article-title":"Severe Refractory Checkpoint Inhibitor-Related Hepatitis Reversed With Anti-Thymocyte Globulin and n-Acetylcysteine","volume":"72","author":"Motomura","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ccell.2025.01.004_bib95","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhepr.2019.02.001","article-title":"Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report","volume":"1","author":"Corrigan","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ccell.2025.01.004_bib96","article-title":"Immune-checkpoint inhibitor-associated grade 3 hepatotoxicity managed with enteric-coated budesonide monotherapy: A case report","volume":"101","author":"Eleftheriotis","year":"2022","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.ccell.2025.01.004_bib97","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","article-title":"Oncogenic Braf induces melanocyte senescence and melanoma in mice","volume":"15","author":"Dhomen","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.01.004_bib98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-1759(93)90329-6","article-title":"Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line","volume":"166","author":"Vidal","year":"1993","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ccell.2025.01.004_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101749","article-title":"Image-guided radiotherapy in an orthotopic mouse model of rectal cancer","volume":"3","author":"Nicolas","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ccell.2025.01.004_bib100","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191515","article-title":"AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer","volume":"217","author":"Varga","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib101","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/PAS.0000000000000453","article-title":"Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases","volume":"39","author":"Johncilla","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2025.01.004_bib102","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1681\/ASN.2021101319","article-title":"alpha-Parvin Defines a Specific Integrin Adhesome to Maintain the Glomerular Filtration Barrier","volume":"33","author":"Rogg","year":"2022","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ccell.2025.01.004_bib103","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2025.01.004_bib104","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjc.6605274","article-title":"Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes","volume":"101","author":"Stumpf","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2025.01.004_bib105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/path.1914","article-title":"Centrosome-chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer","volume":"208","author":"Gerlach","year":"2006","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ccell.2025.01.004_bib106","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic Kras(G12D) causes myeloproliferation via NLRP3 inflammasome activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.01.004_bib107","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib108","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.ccell.2025.01.004_bib109","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","article-title":"Extending support for mouse data in the Molecular Signatures Database (MSigDB)","volume":"20","author":"Castanza","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.01.004_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.01.004_bib111","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.01.004_bib112","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41467-022-28803-w","article-title":"Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data","volume":"13","author":"Ianevski","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.01.004_bib113","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.07.048","article-title":"Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis","volume":"175","author":"De Schepper","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.01.004_bib114","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221472","article-title":"Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages","volume":"220","author":"Gonzalez","year":"2023","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2025.01.004_bib115","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1038\/s41598-017-08121-8","article-title":"Classification of M1\/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis","volume":"7","author":"Bertani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2025.01.004_bib116","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203828120","article-title":"sccomp: Robust differential composition and variability analysis for single-cell data","volume":"120","author":"Mangiola","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.01.004_bib117","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1101\/gr.240663.118","article-title":"Benchmark and integration of resources for the estimation of human transcription factor activities","volume":"29","author":"Garcia-Alonso","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib118","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.4238\/gmr.15028493","article-title":"Data integration for identification of important transcription factors of STAT6-mediated cell fate decisions","volume":"15","author":"Jargosch","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.ccell.2025.01.004_bib119","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.immuni.2010.06.011","article-title":"Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming","volume":"32","author":"Elo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.01.004_bib120","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/leu.2017.137","article-title":"MicroRNA-146a reduces MHC-II expression via targeting JAK\/STAT signaling in dendritic cells after stem cell transplantation","volume":"31","author":"Stickel","year":"2017","journal-title":"Leukemia"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:13:04Z","timestamp":1793855584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1535610825000224"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.01.004","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}